Premium Content
Viewing ads is reserved for Premium and Trial members.
You are currently browsing the archive with a Free Basic Account.
UPGRADE ACCOUNT
|
| Download available for Premium Members |
|
 Ofev
|
NEW FOR IDIOPATHIC PULMONARY FIBROSIS (IPF)
CHANGE THE PATH OF IPF
OFEV is indicated for the treatment of IPF in adults
Treat your patients with OFEV - shown to slow decline in lung function when compared to placebo13־
OFEV
nintedanib
Indication: Ofev is indicated in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
Boehringer Ingelheim
Campaign files
Similar ads
Brand: Ofev
Country/Market: UK, Europe
Target: Healthcare Professional (HCP)
Size/duration: Single-page
Publication/Aired:
Thorax - May 2015
Brand files
|
|